IM Cannabis Posts C$0.47 Q2 Loss Per Share Amid Going Concern Doubts
IMCC sits 33% above its 52-week low of $0.097 on light trading volume (0.1× avg).
Summary
IM Cannabis reported a Q2 loss of C$0.47 per share, a material deterioration that follows a series of dilutive financings and a going concern warning. The company has been raising small amounts of capital through deeply dilutive convertible notes, and the widening loss adds pressure on its Nasdaq listing. The loss per share figure is new information not previously disclosed in the timeline. With a market cap around $1.2 million, the company is in a precarious financial position, and this earnings report confirms the negative trend. The Q2 loss widened as revenue dropped and finance expenses rose.
At the time of this announcement, IMCC was trading at $0.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.10 to $2.83. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.